$0.94
7.62%
Nasdaq, Sep 24, 04:19 pm EDT.
ISIN
US44984F3029
Symbol
IVF

INVO Fertility Stock price

$0.94
-0.09 8.51% 1M
-2.41 71.87% 6M
-2.82 74.96% YTD
-33.54 97.27% 1Y
-1,251.86 99.92% 3Y
-94,578.26 100.00% 5Y
-294,911.06 100.00% 10Y
-368,639.06 100.00% 20Y
Nasdaq, Closing price Thu, Sep 24 2026
-0.08 7.62%

Is INVO Fertility a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
$4.5m
Enterprise Value
$2.4m
Net debt
positive
Cash
$3.7m
Shares outstanding
2.3m
Valuation (TTM | estimate)
P/E
negative
P/S
0.6 | 0.4
EV/Sales
0.3 | 0.2
EV/FCF
negative
P/B
0.3
Financial Health
Equity Ratio
35.7%
Return on Equity
-347.9%
ROCE
-30.7%
ROIC
-33.2%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$7.5m | $10.5m
EBITDA
$-5.4m
EBIT
$-5.9m
Net Income
$-7.1m
Free Cash Flow
$-4.8m
Growth (TTM | estimate)
Revenue
13.8% | 53.9%
EBITDA
32.5%
EBIT
32.8%
Net Income
74.8%
Free Cash Flow
27.3%
Margin
Gross
35.3%
EBITDA
-71.3%
EBIT
-78.7%
Net
-94.2%
Free Cash Flow
-63.9%
More
EPS
$-2.7
FCF per Share
$-2.1
Short interest
14.7%
Employees
-
Rev per Employee
-

INVO Fertility Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a INVO Fertility forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a INVO Fertility forecast:

Buy
80%
Hold
20%

Financial data from INVO Fertility

Jun '26
+/-
%
7.53 7.53
14% 14%
100%
- Direct Costs 4.87 4.87
19% 19%
65%
2.66 2.66
5% 5%
35%
- Selling and Administrative Expenses 8.02 8.02
18% 18%
107%
- Research and Development Expense - -
-
-
-5.37 -5.37
32% 32%
-71%
- Depreciation and Amortization 0.56 0.56
36% 36%
7%
EBIT (Operating Income) EBIT -5.93 -5.93
33% 33%
-79%
Net Profit -7.09 -7.09
75% 75%
-94%

In millions USD.

Don't miss a Thing! We will send you all news about INVO Fertility directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

INVO Fertility Stock News

Neutral
GlobeNewsWire
●
about one month ago
SARASOTA, Fla., Aug. 20, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced that Gretchen Collins, M.D.
Neutral
GlobeNewsWire
●
about one month ago
Q2 2026 revenue increased 17% as INVO advances organic growth and a disciplined acquisition strategy focused on established, profitable fertility practices Clinic platform was profitable on an Adjusted EBITDA basis before corporate operating and public company expenses SARASOTA, Fla., Aug. 17, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a hea...
Neutral
GlobeNewsWire
●
3 months ago
23% revenue growth, elimination of all Series C-2 Preferred Stock and warrant liabilities, and a strengthened balance sheet
More INVO Fertility News

Company Profile

INVO BioScience, Inc. focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Medford, MA.

Head office United States
CEO Mr. Shum
Founded 2007
Website invofertility.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today